Full-Time

Developmental or Reproductive Biologists

Posted on 4/21/2024

Conception

Conception

11-50 employees

Biotech firm developing egg cells from blood

Biotechnology
Healthcare

Senior

Berkeley, CA, USA

Category
Computational Biology
Biology Lab & Research
Biology & Biotech
Requirements
  • PhD or equivalent work experience
  • 5+ years of experience in the Follicle/IVF/embryology field
  • General experience in microdissections and micromanipulation is highly desirable
  • Ability to maintain detailed and accurate records
  • Strong communication skills
  • Solid scientific background with a reliable track record in executing experiments
Responsibilities
  • Working with follicle isolations, follicle growth, egg maturation, and other IVF techniques
  • Collaborating closely with other project teams
  • Maintaining detailed and accurate records
  • Having an eye for details

Conception.bio focuses on improving fertility treatments through advanced biotechnology. The company has developed a method to create viable egg cells from blood samples by transforming induced pluripotent stem cells (iPSCs) into mature egg cells. This process allows women to extend their fertility, provides options for couples facing infertility, and supports same-sex male couples wanting biological children. Unlike many competitors, Conception.bio emphasizes a collaborative research environment with a team of skilled scientists dedicated to fertility science. The goal is to offer effective solutions for infertility and enhance reproductive health, making it easier for individuals and couples to achieve their family planning goals.

Company Stage

Series A

Total Funding

$23M

Headquarters

Berkeley, California

Founded

2017

Growth & Insights
Headcount

6 month growth

-5%

1 year growth

31%

2 year growth

31%
Simplify Jobs

Simplify's Take

What believers are saying

  • Growing interest in genetic screening boosts potential partnerships and funding opportunities.
  • Advancements in CRISPR enhance Conception's genetic screening and disease prevention capabilities.
  • Rising demand for fertility preservation expands Conception's market reach.

What critics are saying

  • Ethical concerns about iPSCs could lead to public backlash and regulatory challenges.
  • Competition from companies like Dioseve may impact Conception's market share.
  • High development costs of stem cell technologies may limit accessibility and adoption.

What makes Conception unique

  • Conception uses iPSCs to create viable human eggs from skin cells.
  • Their technology allows male-male couples to have biological children.
  • Conception offers genetic screening to prevent hereditary diseases in embryos.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE